Barbara A. Payne, principal of Utah Medical Products, Inc. (NASDAQ: UTMD – Get Rating), sold 2,000 shares of Utah Medical Products in a trade dated Wednesday, May 11. The shares were sold at an average price of $85.20, for a total value of $170,400.00. Following the sale, the director now owns 5,338 shares of the company, valued at approximately $454,797.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

NASDAQ:UTMD opened at $85.05 on Thursday. The company has a 50-day moving average of $87.51 and a 200-day moving average of $95.57. The company has a market capitalization of $310.86 million, a price-earnings ratio of 20.35 and a beta of 0.25. Utah Medical Products, Inc. has a 1-year low of $81.01 and a 1-year high of $133.87.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 6. Investors of record on Friday, June 17 will receive a dividend of $0.29. The ex-dividend date is Thursday, June 16. This represents a dividend of $1.16 on an annualized basis and a yield of 1.36%. Utah Medical Products’ payout ratio is 27.75%.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They established a “Strong Buy” rating for the company.

A number of large investors have recently increased or reduced their stakes in UTMD. HealthInvest Partners AB increased its position in Utah Medical Products by 40.0% in Q1. HealthInvest Partners AB now owns 56,000 shares of the medical device supplier worth $5,032,000 after buying an additional 16,000 shares in the last quarter. JPMorgan Chase & Co. increased its position in Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical device supplier worth $9,145,000 after buying 14,693 additional shares in the last quarter. FMR LLC increased its position in Utah Medical Products by 2.4% in the 1st quarter. FMR LLC now owns 488,255 shares of the medical device supplier worth $43,089,000 after purchasing an additional 11,248 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in Utah Medical Products in Q4 for approximately $1,086,000. Finally, James Investment Research Inc. acquired a new stake in Utah Medical Products in Q1 for a value of approximately $384,000. Institutional investors hold 71.44% of the company’s shares.

Utah Medical Products Company Profile (Get an evaluation)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Recommended Stories

Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.